AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
NEXGEL, Inc.
Video analysis: NXGL
All videosNo video analysis for this stock yet. Request one from our team.
News: NXGL
NEXGEL ANNOUNCES LEADERSHIP TRANSITION AND STRATEGIC REVIEW INITIATIVE
LANGHORNE, Pa. , Aug. 20, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL") today announced a series of leadership, governance and strategic initiatives designed to strengthen operational execution, improve liquidity, and enhance long-term shareholder value. The actions include the appointment of Brian Kieser as Interim Chief Executive Officer and the formation of a Special Committee for Strategic Review and Value Creation.
NEXGEL Reports Second Quarter 2026 Financial Results
LANGHORNE, Pa., Aug. 17, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced its second quarter 2026 financial results for the period ending June 30, 2026.
Similar companies
-
Retractable Technologies, Inc.
RVP
·
New York Stock Exchange Arca
Compare
-
Harvard Bioscience, Inc.
HBIO
·
NASDAQ
Compare
-
Femasys Inc.
FEMY
·
NASDAQ
Compare
-
CytoMed Therapeutics Limited
GDTC
·
NASDAQ
Compare
-
Nexalin Technology, Inc.
NXL
·
NASDAQ
Compare
-
Enlivex Therapeutics Ltd.
ENLV
·
NASDAQ
Compare